Literature DB >> 16331652

Enhanced bone formation by transforming growth factor-beta1-releasing collagen/chitosan microgranules.

Jue-Yeon Lee1, Kyoung-Hwa Kim, Seung-Yoon Shin, In-Chul Rhyu, Yong-Moo Lee, Yoon-Jeong Park, Chong-Pyoung Chung, Seung-Jin Lee.   

Abstract

Collagen/chitosan composite microgranules were fabricated as bone substitutes for the purpose of obtaining high bone-forming efficacy. The microgranules have the flexibility to fill various types of defect sites with closer packing. The interconnected pores formed spaces between the microgranules, which allowed new bone ingrowth and vascularization. In addition, the transforming growth factor-beta 1 (TGF-beta1) was incorporated into the microgranules in order to improve bone-healing efficacy. The collagen/chitosan microgranules were fabricated by dropping a mixed solution into a NaOH/ethanol solution. TGF-beta1 was loaded into the collagen/chitosan microgranules by soaking the microgranules in a TGF-beta1 solution. Scanning electron microscopy (SEM) observations and experiments examining the release of TGF-beta1 from chitosan and the collagen/chitosan microgranules were performed. SEM was used to examine the cell morphologies on the microgranules and cell proliferation was evaluated using a dimethylthiazole tetrazolium bromide assay. The differentiated cell function was assessed by measuring the alkaline phosphatase (ALPase) activity as well as detecting an osteocalcin assay. The in vivo bone-regeneration experiments were performed using a rabbit calvarial defect model. TGF-beta1 was released from the collagen/chitosan microgranules at a therapeutic concentration for 4 weeks. SEM indicated that the seeded osteoblastic cells were firmly attached to the microgranules and proliferated in a multilayer manner. The proliferation of the osteoblasts on the TGF-beta1-loaded microgranules was the highest among the different types of microgranules tested. The ALPase activity and osteocalcin level of all the samples increased during the culture period, and the TGF-beta1-loaded microgranules had a significantly higher ALPase activity and osteocalcin content than the other microgranules. The TGF-beta1-loaded microgranules demonstrated a higher bone-regenerative capacity in the rabbit calvarial defects after 4 weeks than the TGF-beta1-unloaded microgranules. (c) 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16331652     DOI: 10.1002/jbm.a.30434

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  15 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

Review 2.  The use of micro- and nanospheres as functional components for bone tissue regeneration.

Authors:  Huanan Wang; Sander C G Leeuwenburgh; Yubao Li; John A Jansen
Journal:  Tissue Eng Part B Rev       Date:  2011-09-23       Impact factor: 6.389

Review 3.  Nanostructured injectable cell microcarriers for tissue regeneration.

Authors:  Zhanpeng Zhang; Thomas W Eyster; Peter X Ma
Journal:  Nanomedicine (Lond)       Date:  2016-05-27       Impact factor: 5.307

Review 4.  Recommendations and considerations for the use of biologics in orthopedic surgery.

Authors:  Stefan Zwingenberger; Christophe Nich; Roberto D Valladares; Zhenyu Yao; Maik Stiehler; Stuart B Goodman
Journal:  BioDrugs       Date:  2012-08-01       Impact factor: 5.807

Review 5.  Resolution of inflammation in bone regeneration: From understandings to therapeutic applications.

Authors:  Hunter Newman; Yuru Vernon Shih; Shyni Varghese
Journal:  Biomaterials       Date:  2021-09-01       Impact factor: 15.304

6.  Rapid biomineralization of chitosan microparticles to apply in bone regeneration.

Authors:  A Champa Jayasuriya; Shane Kibbe
Journal:  J Mater Sci Mater Med       Date:  2009-09-16       Impact factor: 3.896

7.  Co-culture of human bone marrow stromal cells with endothelial cells alters gene expression profiles.

Authors:  Ying Xue; Zhe Xing; Anne Isine Bolstad; Thomas E Van Dyke; Kamal Mustafa
Journal:  Int J Artif Organs       Date:  2013-08-02       Impact factor: 1.595

8.  Inhibition of insulin-like growth factor-1 (IGF-1) expression by prolonged transforming growth factor-β1 (TGF-β1) administration suppresses osteoblast differentiation.

Authors:  Hiromi Ochiai; Shoko Okada; Akiko Saito; Kazuto Hoshi; Haruto Yamashita; Tsuyoshi Takato; Toshifumi Azuma
Journal:  J Biol Chem       Date:  2012-05-09       Impact factor: 5.157

9.  Akt activation is required for TGF-β1-induced osteoblast differentiation of MC3T3-E1 pre-osteoblasts.

Authors:  Eiichi Suzuki; Hiromi Ochiai-Shino; Hideto Aoki; Shoko Onodera; Akiko Saito; Atsushi Saito; Toshifumi Azuma
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

10.  PDGF-induced PI3K-mediated signaling enhances the TGF-β-induced osteogenic differentiation of human mesenchymal stem cells in a TGF-β-activated MEK-dependent manner.

Authors:  Jun Yokota; Naoyuki Chosa; Shunsuke Sawada; Naoto Okubo; Noriko Takahashi; Tomokazu Hasegawa; Hisatomo Kondo; Akira Ishisaki
Journal:  Int J Mol Med       Date:  2013-12-27       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.